A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

A novel coronavirus from patients with pneumonia in China, 2019

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Virological assessment of hospitalized patients with COVID-2019

Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,298

A serological assay to detect SARS-CoV-2 seroconversion in humans

Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769

Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Huang, A. T., Garcia-Carreras, B., Hitchings, M. D. T., Yang, B., Katzelnick, L. C., Rattigan, S. M., Borgert, B. A., Moreno, C. A., Solomon, B. D., Trimmer-Smith, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18450-4 · Cited by 1,026

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

(2020) · Nature Communications · doi:10.1101/2020.04.14.20065771 · Cited by 1,019

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Nie, J., Li, Q., Wu, J., Zhao, C., Hao, H., Liu, H., Zhang, L., Nie, L., Qin, H., Wang, M., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1743767 · Cited by 711

Dual-Function Janus Nanozymes for Performance Evaluation and Application in a Surrogate Virus Neutralization Test with Vaccinated Samples

Kwak, S.-H., Jeong, D. G., Shon, H. K., Kim, D.-H., Lee, T. G., Wi, J., & Na, H. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c12251 · Cited by 6

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies

Mravinacová, S., Jönsson, M., Christ, W., Klingström, J., Yousef, J., Hellström, C., Hedhammar, M., Havervall, S., Thålin, C., Pin, E., et al. (2021) · New Biotechnology · doi:10.1016/j.nbt.2021.10.002 · Cited by 7

Confidence intervals for the COVID-19 neutralizing antibody retention rate in the Korean population

Apio, C., Kamruzzaman, M., & Park, T. (2020) · Genomics & Informatics · doi:10.5808/gi.2020.18.3.e31 · Cited by 6

NeutrobodyPlex - Nanobodies to monitor a SARS-CoV-2 neutralizing immune responsePreprint

Wagner, T. R., Kaiser, P. D., Gramlich, M., Ostertag, E., Ruétalo, N., Junker, D., Häring, J., Traenkle, B., Becker, M., Dulovic, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.22.308338 · Cited by 6

Reframing veterinary vaccine quality control: Integrating alternative assays within lifecycle-based regulatory frameworks

Abousenna, M. S. (2026) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2026.111109 · Cited by 6

A SARS‐CoV‐2 Neutralization Assay Using Single Molecule Arrays

Gilboa, T., Cohen, L., Cheng, C., Lazarovits, R., Uwamanzu‐Nna, A., Han, I., Griswold, K., Barry, N., Thompson, D. B., Kohman, R. E., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202110702 · Cited by 5

An Integrated Research–Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay

Zou, J., Kurhade, C., Chang, H. C., Hu, Y., Meza, J. A., Beaver, D., Trinh, K., Omlid, J., Elghetany, B., Desai, R., et al. (2023) · Viruses · doi:10.3390/v15091855 · Cited by 5

Quantitative microfluidic assay to measure neutralizing and total antibodies for SARS-CoV-2

Bae, H., Lee, D., Kim, H., Jee, Y. S., Kim, J., Min, B., Park, Y.-N., Seo, J.-S., Lee, J., Lee, S., et al. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.135093 · Cited by 6

Fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development

Wang, Y., Troutman, M. C., Hofmann, C., Gonzaléz, A., Song, L., Levin, R., Pixley, H., Kearns, K., DePhillips, P. A., & Loughney, J. W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1356600 · Cited by 5

The development of a rapid, high-throughput neutralization assay using a SARS-CoV-2 reporter

Suzuki, R., Kamiyama, A., Ito, H., Kawashiro, K., Tomiyama, T., Tamura, T., Suzuki, S., Yoshizumi, T., Hotta, K., & Fukuhara, T. (2024) · Journal of Virological Methods · doi:10.1016/j.jviromet.2024.114894 · Cited by 5

Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for in vitro and non-invasive in vivo studies

Utrilla-Trigo, S., Jiménez-Cabello, L., Marín-López, A., Illescas-Amo, M., Andrés, G., Calvo-Pinilla, E., Lorenzo, G., van Rijn, P. A., Ortego, J., & Nogales, A. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.02493-23 · Cited by 5

A deep learning approach predicting the activity of COVID-19 therapeutics and vaccines against emerging variants

Matson, R. P., Comba, I. Y., Silvert, E., Niesen, M. J. M., Murugadoss, K., Patwardhan, D., Suratekar, R., Goel, E.-G., Poelaert, B. J., Wan, K. K., et al. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00471-0 · Cited by 5

Development of COVID-19 Neutralizing Antibody (NAb) Detection Kits Using the S1 RBD Protein of SARS-CoV-2

Choi, D. O., & Lee, K. M. (2021) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2021.53.3.257 · Cited by 5

Evaluación de la respuesta humoral inducida por la vacuna BBIBP-CorV mediante la determinación de anticuerpos neutralizantes en personal sanitario peruano

Soto, A., Charca-Rodriguez, F. D. M., Pareja-Medina, M., Fernández-Navarro, M., Altamirano-Cáceres, K., Chávez, E. S., Raraz-Vidal, J., Cabezudo-Pillpe, N. E., Velarde-Rodríguez, M., & Alcántara-Díaz, A. M. (2021) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2021.384.9244 · Cited by 5

Pseudovirus-Based Assays for the Measurement of Antibody-Mediated Neutralization of SARS-CoV-2

Balinsky, C. A., Jani, V., Sun, P., Williams, M., Defang, G. N., & Porter, K. R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2111-0_21 · Cited by 5

Development, analysis, and preclinical evaluation of inactivated vaccine candidate for prevention of Covid-19 disease

Onen, E. A., Sönmez, K., Yıldırım, F., Demirci, E., & Gürel, A. (2022) · All Life · doi:10.1080/26895293.2022.2099468 · Cited by 5

RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers

Aguilar, R., Li, X., Crowell, C. S., Burrell, T., Vidal, M., Rubio, R., Jiménez, A., Hernández-Luis, P., Hofmann, D., Mijočević, H., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03165-22 · Cited by 5

COVID-19 antibody testing: From hype to immunological reality

Gray, C. M., Peter, J., Mendelson, M., Madhi, S. A., & Blackburn, J. M. (2020) · South African Medical Journal · doi:10.7196/samj.2020.v110i9.15155 · Cited by 5

A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination

Abdul, F., Ribaux, P., Caillon, A., Malézieux-Picard, A., Prendki, V., Vernaz, N., Zhukovsky, N., Delhaes, F., Krause, K., & Preynat‐Seauve, O. (2022) · Viruses · doi:10.3390/v14102118 · Cited by 4

Occurrence of False-Positive Tests and Cross-reactions Between COVID-19 and Dengue With Implications During Diagnosis: A Mixed Evidence Synthesis

Digwo, D. C., Elebe, C. P., Chigor, V. N., Madueke, S. N., Ezeh, C. K., & Ike, A. C. (2023) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000116 · Cited by 4

Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening

O’Reilly, S. R., Kenny, G., Alrawahneh, T., Francois, N., Gu, L., Angeliadis, M., d’Autume, V. D. M., Leon, A. G., Feeney, E. R., Yousif, O., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294262 · Cited by 4

Microbial Dynamics and Quality Monitoring in Biopharmaceutical Production

Pashang, R., Gilbride, K. A., & Wenk, J. (2024) · ChemBioEng Reviews · doi:10.1002/cben.202400022 · Cited by 4

Rapid antibody diagnostics for SARS-CoV-2 adaptive immune response

Afzal, A., Iqbal, N., Feroz, S., Ali, A., Ehsan, M. A., Khan, S. A., & Rehman, A. (2021) · Analytical Methods · doi:10.1039/d1ay00888a · Cited by 3

Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection

Taubner, B., Peredo-Wende, R., Ramani, A., Singh, G., Strle, K., & Cady, N. C. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00890-21 · Cited by 4

Neutralizing Antibodies against the SARS-CoV-2 Ancestral Strain and Omicron BA.1 Subvariant in Dogs and Cats in Mexico

Dehesa-Canseco, F., Roxana, P.-U., Carrillo-Guzmán, N., Liljehult-Fuentes, F., la Rosa, J. D. P.-D., Ramírez‐Mendoza, H., Estrada-Franco, J. G., Navarro‐López, R., Hernández, J., & Solís-Hernández, M. (2023) · Pathogens · doi:10.3390/pathogens12060835 · Cited by 4

Equipment-free, gold nanoparticle based semiquantitative assay of SARS-CoV-2-S1RBD IgG from fingertip blood: A practical strategy for on-site measurement of COVID-19 antibodies

Zhu, Z., Ma, X., Zhu, L., Luo, Q., Lin, N., Chen, Z., Zhao, X., Lin, Z., & Cai, Z. (2022) · Talanta · doi:10.1016/j.talanta.2022.123498 · Cited by 4

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects

Dulipsingh, L., Schaefer, E. J., Wakefield, D. B., Williams, K., Halilovic, A., & Crowell, R. E. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17410 · Cited by 5

Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitor

Moquin, S. A., Lakshminarayana, S. B., Balavenkatraman, K. K., Schiller, H., Claas, A., Bhhatarai, B., Loisios-Konstantinidis, I., Vulic, K., Kurhade, C., Kalveram, B., et al. (2025) · npj Drug Discovery. · doi:10.1038/s44386-025-00030-5 · Cited by 3

Control of Coxiella burnetii shedding in a dairy goat herd by annual offspring vaccination

Bauer, B. U., Herms, L., Jahnke, R., Ossowski, N., Walter, M. C., Frangoulidis, D., Runge, M., Ganter, M., & Knittler, M. R. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.07.026 · Cited by 3

Impedance‐based monitoring of titration and neutralization assays with VSV‐G and SARS‐CoV‐2‐spike pseudoviruses

Mildner, A., Einhauser, S., Michaelis, S., von Bieberstein, K. R., Wagner, R., & Wegener, J. (2024) · Applied Research · doi:10.1002/appl.202400097 · Cited by 3

Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial

Thiede, J. M., Gress, A. R., Libby, S. D., Ronayne, C. E., Matchett, W. E., Noren, B., Billings, J. L., Menachery, V. D., Langlois, R. A., Kline, S., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab035 · Cited by 3

Immunological tests: Essential and supportive tools in the fight against COVID-19

Zhang, D., Kukkar, D., & Kim, K. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117291 · Cited by 3

The relationship between the number of COVID-19 vaccines and infection with Omicron ACE2 inhibition at 18-months post initial vaccination in an adult cohort of Canadian paramedics

Yap, J., Kayda, I., Asamoah-Boaheng, M., Haig, S., Kirkham, T. L., Cheskes, S., Demers, P. A., Goldfarb, D. A., & Grunau, B. E. (2023) · Access Microbiology · doi:10.1099/acmi.0.000725.v3 · Cited by 3

Microfluidic-assisted single-cell RNA sequencing facilitates the development of neutralizing monoclonal antibodies against SARS-CoV-2

Wang, Z., Huang, A. S., Tang, L., Wang, J., & Wang, G. (2024) · Lab on a Chip · doi:10.1039/d3lc00749a · Cited by 4

Exploring the Role of Serology Testing to Strengthen Vaccination Initiatives and Policies for COVID-19 in Asia Pacific Countries and Territories: A Discussion Paper

Chotpitayasunondh, T., Fisher, D. A., Hsueh, P., Lee, P., Crespo, K. A. N., & Ruxrungtham, K. (2022) · International Journal of Translational Medicine · doi:10.3390/ijtm2030024 · Cited by 3

Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) Serology in the Vaccination Era and Post Booster Vaccination

Dulipsingh, L., Lang, M., Diffenderfer, M. R., Cook, L., Puff, J., Diaz, L., He, L., & Schaefer, E. J. (2022) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2022.100130 · Cited by 3

Silymarin Functionalized Chitosan Nanoparticles as a Promising Theranostic Nanoplatform for Hepatocellular Carcinoma: Preparation, Characterization and In Vivo Biodistribution Assessment

Nasr, M. S., Eldin, Z. E., Fayez, H., Raslan, M., El-Bayoumy, A. S. A., ABDALLAH, S. O., & El‐Shahawy, A. A. G. (2025) · BioNanoScience · doi:10.1007/s12668-025-01939-x · Cited by 2

Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17–21, 2025

Jordan, R., Archin, N. M., Cagno, V., Feng, J. Y., Guo, H., Herrero, L. J., Janeba, Z., Meanwell, N. A., Moffat, J. F., Neyts, J. H., et al. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106222 · Cited by 2

A dual-reporter HCoV-OC43 for coronavirus biology and countermeasure development

Deng, X., Zou, J., Liang, Z., Ren, P., Shi, P., Menachery, V. D., & Xie, X. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106306 · Cited by 2

Construction of an Immunosensor Based on the Affinity DNA Functional Ligands to the Fc Segment of IgG Antibody

Yang, Q., Liu, Z., Xu, X., Zhao, Z.-H., Fan, Z., Du, B., Xu, J., Xu, J., Wang, J., Liu, B., et al. (2025) · Biosensors · doi:10.3390/bios15110747 · Cited by 2

Integrated Laboratory Evaluation of Rift Valley Fever Virus Antibodies Using the Competitive ELISA and Virus Neutralization Test

Dafalla, O. M., Alashor, A. A., HUSSIEN, M. F., Noureldin, E., Ageep, T. B., Najmi, M. A., Mohamed, M. S., Hakami, A. H., Alrashedi, S. A., Bushlaibi, F. A., et al. (2026) · Pathogens · doi:10.3390/pathogens15030264 · Cited by 2

Neutralization of SARS-CoV-2 by IgM-14 via engagement of two distinct spike epitopes

Wang, Y., Hu, Y., Ku, Z., Yeung, J., Zou, J., Woodson, M., Prokhorov, N. S., Knyazhanskaya, E. S., Zhao, H., Sherman, M. B., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014071 · Cited by 2

Traceable value of immunoglobulin G against receptor-binding domain of SARS-CoV-2 confirmation and application to point-of-care testing system development

Liang, Z., Lu, X., Jiao, X., He, Y., Meng, B., Xie, J., Qu, Z., Zhu, M., Gong, X., Zhao, Y. C., et al. (2023) · Microchimica Acta · doi:10.1007/s00604-023-06004-6 · Cited by 2

Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants

Du, S., Yang, L., Chen, X., Chen, Y., Weng, L., Huang, H., & Pang, S. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151224 · Cited by 2

Development and Validation of Novel Cell‐free Direct Neutralization Assay for SARS-CoV-2

Lim, J. Y., Fiore, A., Le, B., Minzer, C., White, H., Burinski, K., Janwari, H., Wright, D. J., Perebikovsky, S., Davis, R., et al. (2025) · Journal of Virological Methods · doi:10.1016/j.jviromet.2025.115201 · Cited by 2

Testing for SARS-CoV-2

Popadic, D. M. (2021) · Medicinski podmladak · doi:10.5937/mp72-33002 · Cited by 2

Current Challenges for the Effective Management of the COVID-19 Pandemic

Sinha, V., Saxena, S., Pandey, S., Dwivedi, S., Thakur, S., Asea, A. A. A., Dixit, A. K., Dixit, V., Vishvakarma, N. K., & Shukla, D. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-85113-2_8 · Cited by 2

Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova

Ulinici, M., Suljič, A., Poggianella, M., Bonotto, R. M., Rus, K. R., Paraschiv, A., Bonetti, A. M., Todiraş, M., Corlăteanu, A., Groppa, S. A., et al. (2023) · Vaccines · doi:10.3390/vaccines11030637 · Cited by 2

A validate and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA neutralising antibodies for vaccine development and comparison

Antonelli, R., Forconi, V., Molesti, E., Semplici, C., Piu, P., Altamura, M., Dapporto, F., Temperton, N. J., Montomoli, E., & Manenti, A. (2024) · F1000Research · doi:10.12688/f1000research.149578.1 · Cited by 2

Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies

Jung, B. K., Yoon, J. H., Bae, J., Kim, J., Park, M., Lee, S. Y., & Lim, C. S. (2021) · Diagnostics · doi:10.3390/diagnostics11122193 · Cited by 3

Clinical utility of Corona Virus Disease-19 serum IgG, IgM, and neutralizing antibodies and inflammatory markersPreprint

Schaefer, E. J., Comite, F., Dulipsingh, L., Lang, M., Jimison, J., Grajower, M. M., Lebowitz, N. E., Geller, A. S., Diffenderfer, M. R., He, L., et al. (2021) · medRxiv · doi:10.1101/2021.01.19.21249604 · Cited by 2

Combinatorial mRNA vaccination enhances protection against SARS-CoV-2 delta variantPreprint

Hajnik, R. L., Plante, J. A., Liang, Y., Alameh, M., Tang, J., Zhong, C., Adam, A., Scharton, D., Rafael, G. H., Liu, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.08.471664 · Cited by 2

SARS-CoV-2 Delta breakthrough infections in vaccinated patientsPreprint

Zou, J., Xie, X., Liu, M., Shi, P., & Ren, P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.12.488092 · Cited by 2

Immune response of primary and booster immunity of SARS-CoV-2 vaccination among patients with chronic liver diseasePreprint

Song, R., Yang, C., Wang, J., Li, Q., Chen, J., Sun, K., Lv, H., Yang, Y., Liang, J., Ye, Q., et al. (2022) · medRxiv · doi:10.1101/2022.11.12.22282242 · Cited by 2

COVID‐19: Laboratory/Serologic Diagnostics

Chin, D., Eibschutz, L. S., Sobczyk, J., Azami, M., Repajic, M., & Dubé, M. P. (2022) · Wiley eBooks · doi:10.1002/9781119789741.ch3 · Cited by 2

Predicting age-related determinants of heterogeneous outcomes to COVID-19 mRNA vaccines through mathematical modellingPreprint

Deng, X., Farhang‐Sardroodi, S., & Craig, M. (2025) · medRxiv · doi:10.1101/2025.02.14.25322308 · Cited by 3

PyPlaque is an open-source python package for phenotypic analysis of virus plaque assays

De, T., Andriasyan, V., & Yakimovich, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-20075-w · Cited by 2

CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy

Billmeier, A., Khinvasara, K., Lang, F., Mohr, J., Reidenbach, D., Schork, M., Yildiz, I., & Diken, M. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2024416 · Cited by 1

Positive‐strand RNA viruses—a Keystone Symposia report

Cable, J., Denison, M. R., Kielian, M. C., Jackson, W. T., Bartenschlager, R. F. W., Ahola, T., Mukhopadhyay, S., Fremont, D. H., Kuhn, R. J., Shannon, A., et al. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14957 · Cited by 1

A flow cytometry‐based assay to measure neutralizing antibodies against SARS‐CoV ‐2 virus

Pscheidt, V. M., de Souza, P. O., Fazolo, T., Proença‐Módena, J. L., Simeoni, C. L., de Toledo-Teixeira, D. A., Brunetti, N. S., Bispo-dos-Santos, K., Júnior, L. R., & Bonorino, C. (2024) · Cytometry Part A · doi:10.1002/cyto.a.24838 · Cited by 1

Cell-free immuno-profiling on a genetically programmed biochip

Dupin, A., Vonshak, O., Nir, V., Levanon, M., Avidan, N., Divon, Y., Peleg, S., Thompson, S., Noireaux, V., Daube, S. S., et al. (2025) · Nature Nanotechnology · doi:10.1038/s41565-025-02058-0 · Cited by 1

Associated uncertainty estimation during the validation process of TCID50 and FRNT neutralization assays against SARS-CoV-2 variants, used in population surveillance research and correlates of protection

Reyna-Rosas, E., Nieto-Ponce, M., Palencia-Reyes, A., Blancas-Ruíz, C., Carranza, C., Torres, M. G., & Zamudio‐Meza, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1768395 · Cited by 1

Diagnostic Approach to a Patient with Coronavirus Disease

Singhal, V. (2020) · Springer eBooks · doi:10.1007/978-981-15-8681-1_4 · Cited by 1

A Candidate DNA Vaccine Encoding the Native SARS-CoV-2 Spike Protein Induces Anti-Subdomain 1 Antibodies

Frische, A., Gunalan, V., Krogfelt, K. A., Fomsgaard, A., & Lassaunière, R. (2023) · Vaccines · doi:10.3390/vaccines11091451 · Cited by 1

Evaluation of the Abdala Vaccine: Antibody and Cellular Response to the RBD Domain of SARS-CoV-2

Islas-Vázquez, L., Alvarado-Alvarado, Y. C., Cruz‐Aguilar, M., Velázquez-Soto, H., Villalobos-Gonzalez, E., Ornelas-Hall, G., Pérez‐Tapia, S. M., & Martínez, M. D. C. J. (2023) · Vaccines · doi:10.3390/vaccines11121787 · Cited by 2

A magnetic-enhanced FRET biosensor for simultaneous detection of multiple antibodies

Li, L.-H., Lu, Y., Lao, X.-X., Pang, S.-Y., Song, M., Wong, M.-C., Wang, F., Yang, M., & Hao, J.-H. (2024) · Smart Materials in Medicine · doi:10.1016/j.smaim.2023.12.003 · Cited by 1

High-Content Imaging-Based Assay for SARS-CoV-2-Neutralizing Antibodies

Rocha, V. P. C., Machado, B. A. S., Quadros, H. C., Fernandes, A. M. S., Fiuza, B. S. D., Meira, C. S., da Silva, V. T. B., Evangelista, A. F., Fonseca, L. M. D. S., Badaró, R. J. D. S., et al. (2024) · Vaccines · doi:10.3390/vaccines12030236 · Cited by 1

The biology of neutralizing antibody therapy with REGEN-COV

Sasaki, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95646-8.00013-5 · Cited by 1

Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study

Gütlin, Y., Torres, D. A., Gensch, A., Schlotterbeck, A.-K., Stöger, L., Heller, S., Infanti, L., Barut, G. T., Thiel, V., Leuzinger, K., et al. (2024) · Swiss Medical Weekly · doi:10.57187/s.3408 · Cited by 1

Constructing the cGAMP‐Aluminum Nanoparticles as a Vaccine Adjuvant‐Delivery System (VADS) for Developing the Efficient Pulmonary COVID‐19 Subunit Vaccines

Wang, N., Wang, C., Wei, C., Chen, M., Gao, Y., Zhang, Y., & Wang, T. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401650 · Cited by 1

A Live-Cell Imaging-Based Fluorescent SARS-CoV-2 Neutralization Assay by Antibody-Mediated Blockage of Receptor Binding Domain-ACE2 Interaction

Arias-Arias, J. L., Monturiol‐Gross, L., & Corrales‐Aguilar, E. (2025) · BioTech · doi:10.3390/biotech14010010 · Cited by 1

Comparative assessment of four virus neutralization assays for detection of SARS-CoV-2 neutralizing antibodies

Maghsood, F., Dashti, N., Bahadori, T., Golsaz‐Shirazi, F., Moog, C., Amiri, M. M., & Shokri, F. (2025) · Analytical Biochemistry · doi:10.1016/j.ab.2025.115860 · Cited by 1

[Change in serum IgG antibody during the recovery stage of Omicron variant infection in children: an analysis of 110 cases].

Zhang, P.-P., Guo, Y., Chu, Y.-Q., Ji, Q. I., Lian, Y., Li, W., & Yao, L.-N. (2022) · PubMed Central · doi:10.7499/j.issn.1008-8830.2204074 · Cited by 1

Pandemic’s silver lining

Ferrara, F., D’Angelo, S., Erasmus, M. F., Teixeira, A. A. R., Leal‐Lopes, C., Spector, L. P., Pohl, T., Fanni, A. M., Cocklin, S., & Bradbury, A. M. (2022) · mAbs · doi:10.1080/19420862.2022.2133666 · Cited by 2

A Trans-Complementation System for SARS-CoV-2Preprint

Zhang, X., Liu, Y., Liu, J., Bailey, A. L., Plante, K. S., Plante, J. A., Zou, J., Xia, H., Bopp, N., Aguilar, P., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3770930 · Cited by 1

Assessment of Factors Affecting Inactivated COVID-19 (CORONAVAC) Vaccine Response and Antibody Response in Healthcare ProfessionalsPreprint

Özdemir, H. Ö., Tosun, S. Y., Coşkuner, S. A., & Demir, S. (2021) · Research Square · doi:10.21203/rs.3.rs-506854/v1 · Cited by 1

Viruses in the upper respiratory tract of individuals at risk of zoonotic infection and their animals in Vietnam : follow-up and virus discovery

Tu, N. T. K. (2021) · Työväentutkimus Vuosikirja · Cited by 1

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other VariantsPreprint

Liu, J., Liu, Y., Xia, H., Zou, J., Weaver, S. C., Swanson, K. A., Cai, H., Cutler, M. W., Cooper, D., Muik, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.13.460163 · Cited by 1

Application of high-throughput serological tests for controlling zoonotic viral infection in Amazon rainforest and as a strategy to prevent future pandemics (Preprint)Preprint

de Azevedo, M. S. P., Ribeiro, D. G., Santos, F. R. D. S., Soares, S. D. C., Azevedo, V., Bielavsky, M., Naveca, F. G., Lindoso, J. Â. L., Oliveria, A. F. D., Alcântara, L. C. J., et al. (2021) · doi:10.2196/preprints.27747 · Cited by 1

Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with age and gender among health care workersPreprint

Zare, H., Rezapour, H., Fereidouni, A., Nikpour, S., Mahmoudzadeh, S., Royce, S. G., & Fereidouni, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1683390/v1 · Cited by 1

A systematic review and meta-analysis comparing the diagnostic accuracy tests of COVID-19Preprint

Vilca-Alosilla, J. J., Candia-Puma, M. A., Coronel-Monje, K., Goyzueta-Mamani, L. D., Galdino, A. S., Machado‐de‐Ávila, R. A., Giunchetti, R. C., Coelho, E. A. F., & Chávez‐Fumagalli, M. Á. (2022) · medRxiv · doi:10.1101/2022.11.29.22282895 · Cited by 1

Genomic evolution of SARS-CoV-2 variants of concern under in vitro neutralising selection pressure following two doses of the Pfizer-BioNTech BNT162b2 COVID-19 vaccinePreprint

Basile, K., Agius, J. E., Fong, W., McPhie, K. A., Fennel, M., Ko, D., Heuston, L., Lam, C., Arnott, A., Chen, S. C. ‐., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.24.558921 · Cited by 1

Guide pratique à l’intention des laboratoires cliniques pour les tests de sérologie du SRAS-CoV-2

(RLSPC), A. N. D. G. D. T. S. L. S. D. R. D. L. D. S. P. D. C., Charlton, C. L., Kanj, J., Tran, V., Kus, J. V., Gubbay, J. B., Osiowy, C., Robinson, J. L., Sekirov, I., DREBOT, M. A., et al. (2021) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v47i04a01f

Emerging methods in cellular microbiology

Hartland, E. L. (2021) · Cellular Microbiology · doi:10.1111/cmi.13369

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacityPreprint

Koide, A., Panchenko, T., Wang, C., Thannickal, S. A., Romero, L. A., Teng, K. W., Li, F.-Z., Akkapeddi, P., Corrado, A. D., Caro, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.03.454782

Development, Analyze and Preclinical Evaluation of Inactivated Vaccine Candidate For Prevention of COVID-19 DiseasePreprint

Onen, E. A., Sönmez, K., Yıldırım, F., Demirci, E., & Gürel, A. (2021) · Research Square · doi:10.21203/rs.3.rs-960262/v1

PENGUKURAN ANTIBODI KUANTITATIF ANTIBODI ANTI-SARS-COV-2

Indonesia, U. M., & Tambunan, R. T. H. (2021) · Majalah Ilmiah METHODA · doi:10.46880/methoda.vol11no2.pp106-114

SARS-CoV-2 Seropositivity Level in a Cohort of Turkish Health Care Professionals After COVID-19 Vaccine (CoronaVac) and Assessment of Factors Affecting the Antibody Response

Özdemir, H. Ö., Tosun, S. Y., Coşkuner, S. A., & Demir, S. (2022) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20226161 · Cited by 1

Peer Review #1 of "COVID-19: molecular and serological detection methods (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.10180v0.1/reviews/1

Peer Review #2 of "COVID-19: molecular and serological detection methods (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.10180v0.1/reviews/2

The challenge of evaluating of SARS‐CoV ‐2 antibody responses among vaccinated transplant patients

Kitano, T., Campigotto, A. J., & Allen, U. (2022) · Pediatric Transplantation · doi:10.1111/petr.14319

Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) Serology in the Vaccination Era and Post Booster VaccinationPreprint

Dulipsingh, L., Lang, M., Diffenderfer, M. R., Cook, L., Puff, J., Diaz, L., He, L., & Schaefer, E. J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4131160

Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) Serology in the Vaccination Era and Post Booster VaccinationPreprint

Dulipsingh, L., Lang, M., Diffenderfer, M. R., Cook, L., Puff, J., Diaz, L., He, L., & Schaefer, E. J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4156654

Perinatal Diagnostic of SARS-CoV-2 Infection

Vauloup‐Fellous, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-29136-4_8

Diagnosis of COVID-19

Murray, V., & Hou, C. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91812-1.00018-4

The Importance of Qualitative/Quantitative Analytical Tools in COVID-19 Vaccine Development

Seyfinejad, B., Molavi, O., & Jouyban, A. (2023) · ImmunoAnalysis · doi:10.34172/ia.2023.08

A deep learning framework for predicting the neutralizing activity of COVID-19 therapeutics and vaccines against evolving SARS-CoV-2 variantsPreprint

Matson, R. P., Comba, I. Y., Silvert, E., Niesen, M. J. M., Murugadoss, K., Padwardhan, D., Suratekar, R., Goel, E.-G., Poelaert, B. J., Wan, K. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.24.563847

WITHDRAWN: Neutralization and immunoperoxidase to estimate the immunogenicity of recombinant human rotavirus VP6 structural protein in vitro after insertion of the antibodies into cells using electroporationPreprint

Kamel, M. A., Shokeer, A., Hegazy, U. M., El-Hakim, A. E., Elsayed, O. E.-F. R., Barakat, A., Mohamed, A. F., Hamza, I. A., Fuentes, C., Pintó, R. M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4213219/v1

Respuesta inmune humoral contra SARS-COV-2 otorgada por Sputnik V y Sinopharm en población boliviana

Oliva, B. G. M., Rossell, E., Ulloa, D., Kopa, D. P. B., & Torrez, R. E. G. (2024) · Orbis Tertius - UPAL · doi:10.59748/ot.v8i15.147

PyPlaque: an Open-source Python Package for Phenotypic Analysis of Virus Plaque AssaysPreprint

De, T., Andriasyan, V., & Yakimovich, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.07.603274

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples

Bennett, R. S., Postnikova, E. N., Liang, J. Y., Gross, R., Mazur, S., Dixit, S., Lukin, V. V., Kocher, G., Yu, S., Georgia, S., et al. (2021) · Viruses · doi:10.3390/v13050893 · Cited by 29

Development of a SARS-CoV-2 monoclonal antibody panel and its applicability as a reagent in high-throughput fluorescence reduction neutralization and immunohistochemistry assaysPreprint

Coelho, G. M., Cataneo, A. H. D., Raboni, S. M., Nogueira, M. B., de Paula, C. B. V., Almeida, A. C., Rogerio, V. Z., Zanchin, N. I. T., de Noronha, L., Zanluca, C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.29.542720

A flow cytometry‐based assay to measure neutralizing antibodies against SARS‐CoV ‐2 virus

Pscheidt, V. M., de Souza, P. O., Fazolo, T., Proença‐Módena, J. L., Simeoni, C. L., de Toledo-Teixeira, D. A., Brunetti, N. S., Bispo-dos-Santos, K., Júnior, L. R., & Bonorino, C. (2024) · Cytometry Part A · doi:10.1002/cyto.a.24838 · Cited by 1

Development of an anti‐SARS‐CoV‐2 monoclonal antibody panel and its applicability as a reagent in high‐throughput fluorescence reduction neutralization and immunohistochemistry assays

Coelho, G. M., Cataneo, A. H. D., Raboni, S. M., Nogueira, M. B., de Paula, C. B. V., Almeida, A. C., Rogerio, V. Z., Zanchin, N. I. T., de Noronha, L., Zanluca, C., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29111 · Cited by 3

A Novel Adaptive Platform for Rapid, Simple Flow-Based Antibody Detection Devices Predicts NAb Levels to SARS-CoV-2

Markmann, A., Bhowmik, D. R., Jiang, B., Vanna, U. P., Hoy, M. V., Wang, F., Hou, Y., Margolis, D., Baric, R. S., de Silva, A., et al. (2026) · Pathogens and Immunity · doi:10.20411/pai.v11i1.910